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from the prevention of motor vehicle accidents, through the effective management of cognitive impairment. The medical costs were from published sources. The cost of accidents was based on estimates provided by the National Highway and Traffic Administration. The value of patient time came from official wages reported by the Bureau of Labor Statistics. A 3% annual discount rate was applied. The price year was 2010 and the costs were expressed in US $.
Analysis of uncertainty:
One-way sensitivity analyses were carried out on all the model inputs.
Results
In a hypothetical cohort of 1,000 patients receiving treatment with lactulose, the number of accidents prevented was 205.94 with treatment, 202.20 with rapid testing, 204.164 with standard testing, and 205.94 with neuropsychological examination. The net programme costs (costs minus savings) were -$2.4 million with treatment, -$3.6 million with rapid testing, -$3.4 million with standard testing, and -$1.7 million with neuropsychological examination.
All strategies were cheaper and more effective than no treatment, due to the reduction in motor vehicle accidents. The cost per accident prevented was $30,469 with treatment, $24,454 with rapid testing, $25,470 with standard testing, and $33,742 with neuropsychological examination. The rapid test and standard tests were preferred, both in the main analysis and in the sensitivity analyses.
In the cohort receiving treatment with rifaximin, the number of accidents prevented was 279.49 with treatment, 274.41 with rapid testing, 277.07 with standard testing, and 279.49 with neuropsychological examination. The net programme costs were $35.1 million with treatment, $25.0 million with rapid testing, $25.3 million with standard testing, and $19.5 million with neuropsychological examination.
